Danaher insider exercises options and reports sales at $219.2131–$219.2321

Rhea-AI Filing Summary

Danaher (DHR) insider transaction: Senior Vice President and General Counsel Brian W. Ellis reported option exercises and same‑day sales on 11/12/2025. He exercised employee stock options at $58.59 and sold the resulting shares in open market transactions at weighted average prices disclosed in footnotes.

Ellis exercised 7,109 options at $58.59, then sold 7,109 shares at $219.2131. He also exercised 14,667 options at $58.59, then sold 14,667 shares at $219.2321. Following these transactions, he beneficially owned 14,553 shares directly.

Footnotes state the sale prices were weighted averages within disclosed ranges, and describe the vesting schedules of the original option grants.

Insider Trade Summary

Net Seller: 21,776 shares ($4,773,863)

Net Sell 6 txns

Insider Ellis Brian W

Role Senior Vice President - GC

Sold 21,776 shs ($4.77M)

Type	Security	Shares	Price	Value
Exercise	Employee stock option (right to buy)	7,109	$0.00	--
Exercise	Employee stock option (right to buy)	14,667	$0.00	--
Exercise	Common Stock	7,109	$58.59	$417K
Sale	Common Stock	7,109	$219.2131	$1.56M
Exercise	Common Stock	14,667	$58.59	$859K
Sale	Common Stock	14,667	$219.2321	$3.22M

Holdings After Transaction: Employee stock option (right to buy) — 0 shares (Direct); Common Stock — 21,662 shares (Direct)

Footnotes (1)

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.110 to $219.410, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. One fifth of the options granted became exercisable on each of the first five anniversaries of the grant date, which was February 24, 2016. Date shown is grant date. One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ellis Brian W

(Last) (First) (Middle)

2200 PENNSYLVANIA AVENUE, NW, SUITE 800W

(Street)

WASHINGTON DC 20037

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President - GC

3. Date of Earliest Transaction (Month/Day/Year)
11/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/12/2025		M		7,109	A	$58.59	21,662	D
Common Stock	11/12/2025		S		7,109	D	$219.2131	14,553	D
Common Stock	11/12/2025		M		14,667	A	$58.59	29,220	D
Common Stock	11/12/2025		S		14,667	D	$219.2321(1)	14,553	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee stock option (right to buy)	$58.59	11/12/2025		M			7,109	(2)	02/24/2026	Common Stock	7,109	$0	0	D
Employee stock option (right to buy)	$58.59	11/12/2025		M			14,667	02/24/2016(3)	02/24/2026	Common Stock	14,667	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.110 to $219.410, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. One fifth of the options granted became exercisable on each of the first five anniversaries of the grant date, which was February 24, 2016.

3. Date shown is grant date. One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date.

Remarks:

	/s/ James F. O'Reilly, attorney-in-fact for Brian W. Ellis	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Danaher (DHR) report on Form 4 for Brian W. Ellis?

He reported exercising employee stock options and selling the resulting shares on 11/12/2025, with updated direct ownership following the transactions.

How many Danaher shares did Ellis sell and at what prices?

He sold 7,109 shares at a weighted average price of $219.2131 and 14,667 shares at a weighted average price of $219.2321.

What was the option exercise price for the Danaher options?

The employee stock options were exercised at $58.59 per share.

How many Danaher shares does Ellis own after these transactions?

Following the reported transactions, Ellis directly owned 14,553 shares.

What dates and vesting terms are noted for the options?

Footnotes indicate a grant date of 02/24/2016 with vesting over anniversaries and an expiration date of 02/24/2026 for one grant.

Were the reported sale prices exact or averaged?

They were weighted average prices, with sales occurring within stated ranges; detailed breakdowns are available upon request as noted.